Claims for Patent: 4,820,731

Summary for Patent: 4,820,731

Title:	Parenteral dietary supplement and method of minimizing effects of infection through diet
Abstract:	Disclosed is a method of minimizing infection and minimizing the risks of infection in at risk animals and patients. A dietary supplement to accomplish this objective is also disclosed. The method includes the step of administering a diet rich in .omega.3 fatty acids, for example by adding a substantial proportion of fish oils to the diet. The dietary supplement is particularly well suited to patients receiving total parenteral nutrition. A parenteral diet or diet supplement containing a mixture of oils, one rich in .omega.3 fatty acids and the other rich in .omega.6 fatty acids is disclosed.
Inventor(s):	Mascioli; Edward A. (Cambridge, MA), Blackburn; George L. (Jamaica Plain, MA), Bistrian; Bruce R. (Ipswitch, MA), Babayan; Vigen K. (Waban, MA)
Assignee:	New England Deaconess Hospital Corporation (Boston, MA)
Application Number:	07/207,122
Patent Claims:	1. A dietary supplement for parenteral administration comprising: at least 10% by weight of an oily fraction formed of a mixture of oils selected from a group consisting of oils which have .omega.6 fatty acids as their primary fatty acids and oils which have .omega.3 fattyy acids as their primary fatty acids, said oils having .omega.3 fatty acids as their primary fatty acids forming 10-90% by weight of said oily fraction; 1-2% by weight emulsifier; and sterile water. 2. The dietary supplement of claim 1 wherein said emulsifier is selected from a group consisting of egg yolk phospholipids and soybean phospholipids. 3. The dietary supplement of claim 2 wherein said dietary supplement further comprises 1-3 percent by weight of an osmolality modifier. 4. The dietary supplement of claim 3 wherein said osmolality modifier comprises glycerin. 5. The dietary supplement of claim 1 wherein said oils which have .omega.6 fatty acids as their primary fatty acids comprise oils having linoleic acid as their primary .omega.6 fatty acid. 6. The dietary supplement of claim 5 wherein said oils having linoleic acid as their primary .omega.6 fatty acid are selected from a group consisting of safflower, sunflower and soybean oils. 7. The dietary supplement of claim 1 wherein said oils having .omega.3 fatty acids as their primary fatty acid source cmprise fish oils. 8. The dietary supplement of claim 7 wherein said fish oils are selected from a group consisting of oils derived from herring, anchovy, and menhaden. 9. The dietary supplement of claim 1 wherein said oily fraction comprises 10-20% by weight of said dietary supplement. 10. The dietary supplement of claim 1 wherein said oils having 107 3 fatty acids as their primary fatty acids comprise concentrated .omega.3 fatty acid containing oils. 11. A diety for total parenteral nutrition comprising: at least 10% by weight of an oily fraction formed of a mixture of oils selected from a group consisting of oils which have .OMEGA.6 fatty acids as their primary fatty acids and oils which have .omega.3 fatty acids as their primary fatty acids, said oils having .omega.3 fatty acids as their primary fatty acids forming 10-90% by weight of said oily fraction; 1-2% by weight emulsifier; and sterile water. 12. The diet for total parenteral nutrition of claim 11 wherein said emulsifier is selected from a group consisting of egg yolk phospholipids and soybean phospholipids. 13. The diet for total parenteral nutrition of claim 11 further comprising 1-3% by weight of an osmolality modifier. 14. The diet for total parenteral nutrition of claim 13 wherein said osmolality modifier comprises glycerin. 15. The diet for total parenteral nutrition of claim 11 wherein said oils which have .omega.6 fatty acids as their primary fatty acid comprise oils having linoleic acid as their primary .omega.6 fatty acid. 16. The diet for total parenteral nutrition of claim 15 wherein said oils having linoleic acid as their primary .omega.6 fatty acid are selected from a group consisting of safflower, sunflower and soybean oils. 17. The diet for total parenteral nutrition of claim 11 wherein said oils having .omega.3 fatty acids as their primary fatty acids comprise fish oils. 18. The diet for total parenteral nutrition of claim 17 wherein said fish oils are selected from a group consisting of oils derived from herring, anchovy, and menhaden. 19. The diet for total parenteral nutrition of claim 11 wherein said oily fraction comprises 10-20% by weight of said dietary supplement. 20. The diet for total parenteral nutrition of claim 11 wherein said oils having .omega.3 fatty acids as their primary fatty acids comprise concentrated .omega.3 fatty acid containing oils.

Details for Patent 4,820,731

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23